Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology
- PMID: 21651988
- DOI: 10.1016/j.micinf.2011.05.002
Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology
Abstract
There is little known concerning the disease caused by Zaire ebolavirus (ZEBOV) when inhaled, the likely route of exposure in a biological attack. Cynomolgus macaques, rhesus macaques, and African green monkeys were exposed to aerosolized ZEBOV to determine which species might be the most relevant model of the human disease. A petechial rash was noted on cynomolgus and rhesus macaques after fever onset but not on African green monkeys. Fever duration was shortest in rhesus macaques (62.7 ± 16.3 h) and longest in cynomolgus macaques (82.7 ± 22.3h) and African green monkeys (88.4 ± 16.7h). Virus was first detectable in the blood 3 days after challenge; the level of viremia was comparable among all three species. Hematological changes were noted in all three species, including decreases in lymphocyte and platelet counts. Increased blood coagulation times were most pronounced in African green monkeys. Clinical signs and time to death in all three species were comparable to what has been reported previously for each species after parenteral inoculation with ZEBOV. These data will be useful in selection of an animal model for efficacy studies.
Published by Elsevier Masson SAS.
Similar articles
-
Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.Vet Pathol. 2013 May;50(3):514-29. doi: 10.1177/0300985812469636. Epub 2012 Dec 23. Vet Pathol. 2013. PMID: 23262834
-
Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.J Infect Dis. 2007 Nov 15;196 Suppl 2:S323-8. doi: 10.1086/520589. J Infect Dis. 2007. PMID: 17940967
-
Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic.Arch Virol Suppl. 1996;11:115-34. doi: 10.1007/978-3-7091-7482-1_11. Arch Virol Suppl. 1996. PMID: 8800793
-
Animal models for ebolavirus countermeasures discovery: what defines a useful model?Expert Opin Drug Discov. 2015 Jul;10(7):685-702. doi: 10.1517/17460441.2015.1035252. Epub 2015 May 25. Expert Opin Drug Discov. 2015. PMID: 26004783 Review.
-
Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston).Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):391-8. doi: 10.1016/j.cimid.2007.05.005. Epub 2007 Jul 3. Comp Immunol Microbiol Infect Dis. 2007. PMID: 17610952 Review.
Cited by
-
A characterization of aerosolized Sudan virus infection in African green monkeys, cynomolgus macaques, and rhesus macaques.Viruses. 2012 Oct 15;4(10):2115-36. doi: 10.3390/v4102115. Viruses. 2012. PMID: 23202456 Free PMC article.
-
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease.EFSA J. 2017 Jul 18;15(7):e04890. doi: 10.2903/j.efsa.2017.4890. eCollection 2017 Jul. EFSA J. 2017. PMID: 32625555 Free PMC article.
-
Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates.J Infect Dis. 2023 Nov 13;228(Suppl 7):S604-S616. doi: 10.1093/infdis/jiad137. J Infect Dis. 2023. PMID: 37145930 Free PMC article.
-
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x. Signal Transduct Target Ther. 2024. PMID: 39256346 Free PMC article. Review.
-
The non-human primate model of tuberculosis.J Med Primatol. 2012 Jun;41(3):191-201. doi: 10.1111/j.1600-0684.2012.00536.x. Epub 2012 Mar 20. J Med Primatol. 2012. PMID: 22429048 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical